Outcome after Midam Regimen and Impact of Post-Remission Strategy in Patients with Relapsing or Refractory Acute Myeloid Leukemia

被引：0
|
作者：
Bahashwan, Salem
Molucon-Chabrot, Cecile
Hermet, Eric
Ravinet, Aurelie
Douge, Aurore
Veronese, Lauren
Tchirkov, Andrei
Lemal, Richard
Berger, Marc G.
Tournilhac, Olivier
Bay, Jacques-Olivier
Guieze, Romain
机构：
来源：
BLOOD | 2017年 / 130卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
3900
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Outcome and impact of post-remission strategy after MIDAM regimen in patients with relapsing or refractory acute myeloid leukemia
    Bahashwan, Salem
    Molucon-Chabrot, Cecile
    Hermet, Eric
    Ravinet, Aurelie
    Douge, Aurore
    Veronese, Lauren
    Tchirkov, Andrei
    Lemal, Richard
    Berger, Marc G.
    Veyrat-Masson, Richard
    Tournilhac, Olivier
    Bay, Jacques-Olivier
    Guieze, Romain
    [J]. AMERICAN JOURNAL OF HEMATOLOGY, 2019, 94 (01) : E32 - E35
  • [2] Advantage of MIDAM Protocol in Treatment of Elderly Patients With Refractory and Relapsing Acute Myeloid Leukemia
    Filanovsky, Kalman
    Shvidel, Lev
    Shtalrid, Mordechai
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (07) : E115 - E116
  • [3] Post-remission therapy for acute myeloid leukemia
    Schlenk, Richard F.
    [J]. HAEMATOLOGICA, 2014, 99 (11) : 1663 - 1670
  • [4] Impact of different post-remission strategies on quality of life in patients with acute myeloid leukemia
    Messerer, Doyle
    Engel, Jutta
    Hasford, Joerg
    Schaich, Markus
    Ehninger, Gerhard
    Sauerland, Cristina
    Buechner, Thomas
    Schumacher, Andrea
    Krahl, Rainer
    Niederwieser, Dietger
    Krauter, Juergen
    Ganser, Arnold
    Creutzig, Ursula
    Doehner, Hartmut
    Schlenk, Richard F.
    [J]. HAEMATOLOGICA, 2008, 93 (06) : 826 - 833
  • [5] Post-remission therapy of acute myeloid leukemia in first remission
    Kim, ST
    Kim, K
    Lee, SH
    Kim, WS
    Jung, CW
    Lee, MH
    Park, K
    [J]. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2005, 11 (02) : 59 - 59
  • [6] Advantage of MIDAM Protocol in Treatment of Elderly Patients With Refractory and Relapsing Acute Myeloid Leukemia Reply
    Chevallier, Patrice
    Delaunay, Jacques
    Turlure, Pascal
    Pigneux, Arnaud
    Hunault, Mathilde
    Garand, Richard
    Guillaume, Thierry
    Avet-Loiseau, Herve
    Dmytruk, Nathalia
    Girault, Stephane
    Milpied, Noel
    Ifrah, Norbert
    Mohty, Mohamad
    Harousseau, Jean-Luc
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (07) : E117 - E118
  • [7] Azacitidine as the post-remission therapy for elderly patients with acute myeloid leukemia
    Yamamoto, Ryusuke
    Yokoyama, Akihiro
    Yoneda, Mie
    Ohashi, Kota
    Hosoda, Toru
    Kagoo, Toshiya
    Boku, Saigen
    Ueno, Hironori
    Yano, Takahiro
    [J]. ANNALS OF HEMATOLOGY, 2014, 93 (12) : 2081 - 2082
  • [8] Azacitidine as the post-remission therapy for elderly patients with acute myeloid leukemia
    Ryusuke Yamamoto
    Akihiro Yokoyama
    Mie Yoneda
    Kota Ohashi
    Toru Hosoda
    Toshiya Kagoo
    Saigen Boku
    Hironori Ueno
    Takahiro Yano
    [J]. Annals of Hematology, 2014, 93 : 2081 - 2082
  • [9] Impact of Choice of Induction Regimen on Overall Survival and Post-Remission Survival Among Older Adults with Acute Myeloid Leukemia
    McCrum, Kelli
    LaPorte, Justin
    Bashey, Asad
    Solomon, Scott R.
    Morris, Lawrence E.
    Holland, H. Kent
    Solh, Melhem
    [J]. BLOOD, 2021, 138
  • [10] Race and intensity of post-remission therapy in acute myeloid leukemia
    Brady, Anna K.
    Fu, Alex Z.
    Earl, Marc
    Kalaycio, Matt
    Advani, Anjali
    Saunthararajah, Yogen
    Sobecks, Ronald
    Copelan, Edward
    Sekeres, Mikkael A.
    [J]. LEUKEMIA RESEARCH, 2011, 35 (03) : 346 - 350
12345